Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2012
03/29/2012DE102010046837A1 Phenylchinazolinderivate Phenylchinazolinderivate
03/29/2012CA2812699A1 Hepatitis c virus inhibitors
03/29/2012CA2812319A1 Matrix metalloproteinase inhibitors
03/29/2012CA2811895A1 Cyclopropane compounds
03/28/2012EP2432776A1 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
03/28/2012EP2432768A1 Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
03/28/2012EP2432762A1 Insecticidal arylpyrrolines
03/28/2012EP2250163B1 Hepatitis c virus inhibitors
03/28/2012EP2188276B1 Substituted hydantoins
03/28/2012EP1956008B1 Organic compound, charge-transporting material, composition for charge-transporting material and organic electroluminescent device
03/28/2012EP1951690B1 Heterocyclic cetp inhibitors
03/28/2012EP1682537B1 Modulators of cellular adhesion
03/28/2012EP1472234B1 Quinazolinone derivatives and their use as cb agonists
03/28/2012CN1960969B Histamine H3 receptor agents, preparation method and therapeutic uses thereof
03/28/2012CN102395580A Crystalline polymorphic form 631
03/28/2012CN102395579A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
03/28/2012CN102395578A Compounds for the treatment of metabolic disorders
03/28/2012CN102395577A Diazepinedione derivative
03/28/2012CN102395576A Jak kinase modulating quinazoline derivatives and methods of use thereof
03/28/2012CN102395574A Process for preparation of bezoyl amino heterocyclyl compounds
03/28/2012CN102395571A Novel triazine derivative and pharmaceutical composition containing same
03/28/2012CN102395567A Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
03/28/2012CN102395565A Compounds having antiparasitic or anti-infectious activity
03/28/2012CN102391255A Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
03/28/2012CN102391254A Preparation method of Candesartan
03/28/2012CN102391253A Synthetic technology of azelastine hydrochloride
03/28/2012CN102391171A Novel Substituted 3-Sulfur Indoles
03/28/2012CN101550132B Arylvinylazacycloalkane compounds and methods of preparation and use thereof
03/28/2012CN101218237B Oxime derivative and preparations thereof
03/27/2012US8143424 Thyroid like compounds
03/27/2012US8143422 Benzimidazole derivatives
03/27/2012US8143420 Bifunctional and trifunctional nitrone spin trapping compounds and uses thereof
03/27/2012US8143397 Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof
03/27/2012US8143300 Inhibitors of cellular necrosis
03/27/2012US8143288 Inhibitors of HCV replication
03/27/2012US8143279 Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
03/27/2012US8143251 Triazolotriazines as kinase inhibitors
03/27/2012CA2552304C Labeling reagents, labeled analytes, including mixtures thereof, and fragment ions derived therefrom and methods for the analysis thereof
03/27/2012CA2447091C Methods for the treatment and prevention of pain using stress-activated protein kinase
03/22/2012WO2012037187A2 Preparation of crystalline bazedoxifene and its salts
03/22/2012WO2012037132A1 Phtalazine derivatives as jak1 inhibitors
03/22/2012WO2012036482A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/22/2012WO2012036278A1 Glycine transporter inhibitor
03/22/2012WO2012036276A1 Glycine transporter inhibitory substance
03/22/2012WO2012036253A1 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine.
03/22/2012WO2012035436A1 Plinabulin prodrug analogs and therapeutic uses thereof
03/22/2012WO2012035421A2 Pyridine compounds and the uses thereof
03/22/2012WO2012035158A1 Pyrazine derivatives as enac blockers
03/22/2012WO2012035124A1 Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors
03/22/2012WO2012035011A1 Pesticidal arylpyrrolidines
03/22/2012WO2012034957A1 Pesticidal pyrroline n-oxide derivatives
03/22/2012WO2011156543A3 Inhibitors of hcv ns5a protein
03/22/2012US20120071669 process for preparation of eletriptan and salt thereof
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071651 Processes for Preparing 1,2-Substituted Cyclopropyl Derivatives
03/22/2012US20120071524 Compounds for treatment of cancer
03/22/2012US20120071489 Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
03/22/2012US20120071480 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
03/22/2012US20120071478 Substituted benzotriazines and quinoxalines as inhibitors of p7os6 kinase
03/22/2012US20120071477 Cdki pathway inhibitors and uses thereof
03/22/2012US20120071472 Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity
03/22/2012US20120070856 Cross-linking agents
03/22/2012US20120070830 Stabilization of ozone-labile fluorescent dyes by thiourea
03/22/2012US20120068170 Materials for organic electroluminescent devices
03/22/2012DE102010045797A1 Verbindungen für die Diagnostik neurodegenerativer Erkrankungen am Riechepithel Compounds for the diagnosis of neurodegenerative diseases of the olfactory epithelium
03/22/2012CA2812088A1 Phtalazine derivatives as jak1 inhibitors
03/22/2012CA2811479A1 Pyridine compounds and the uses thereof
03/22/2012CA2811080A1 Heterocyclic compound
03/22/2012CA2811076A1 Pyrazine derivatives as enac blockers
03/21/2012EP2431357A2 3-Aminopyrrolidine Derivatives as Modulators of Chemokine Receptors
03/21/2012EP2431035A1 Novel Triazole Derivatives with Improved Receptor Activity and Bioavailability Properties as Ghrelin Antagonists of Growth Hormone Secretagogue Receptors
03/21/2012EP2430016A2 Inhibitors of inv(16) leukemia
03/21/2012EP2430015A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases
03/21/2012EP2430014A1 Antiviral compounds
03/21/2012EP2430013A1 Heteroaryl compounds as pikk inhibitors
03/21/2012EP2430006A1 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof, and therapeutic use thereof
03/21/2012EP1439174B1 4-IMIDAZOLIN-2-ONE COMPOUNDS AS p38 MAP KINASE INHIBITORS
03/21/2012EP1422218B1 Antiviral agent
03/21/2012CN102388044A Heterocyclic inhibitors of histamine receptors for the treatment of disease
03/21/2012CN102388037A Quinazolinones as prolyl hydroxylase inhibitors
03/21/2012CN102388035A Benzimidazole derivatives and their use for modulating the gabaa receptor complex
03/21/2012CN102388025A Pyrimidopyridazine derivatives useful as p38 mapk inhibitors
03/21/2012CN102388023A Organic compounds and their uses
03/21/2012CN102386330A Quinoxaline derivative, and organic semiconductor device, electric field light emitting device, and electronic device which have the same
03/21/2012CN102382107A Pyrazole tetrazole carboxamide and synthesis method thereof
03/21/2012CN102382106A Aniline substituted quinazoline derivative
03/21/2012CN102382105A Bipolar host material used for blue emitting phosphor
03/21/2012CN102382102A Amide compound
03/21/2012CN102382065A Aniline substituted quinazoline derivative
03/21/2012CN102382063A 6-amino-5-cyano-pyrimidine-4-ones compound used for improving perception, power of concentration, learning efficiency, and/or memory power
03/21/2012CN102382028A Maleimide compound, its preparation and application
03/21/2012CN101801384B Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
03/21/2012CN101513402B Antiviral agent
03/21/2012CN101495462B Pyrimidine derivatives and their use as pesticides
03/21/2012CN101268066B A process for the preparation of sartan derivatives and intermediates useful in such process
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138339 Inhibitors of protein kinases
03/20/2012US8138195 Inhibitors of human phosphatidylinositol 3-kinase delta
03/20/2012US8138191 Inhibitor compounds and cancer treatment methods
03/20/2012US8138182 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 626